NUMI.V

Numinus Wellness Inc.

Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology

VANCOUVER, BC, July 29, 2021 - Numinus Wellness Inc.Β ("Numinus") (TSXV:Β NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its fiscal third quarter results ended May 31, 2021. In the third quarter, Numinus maintained a healthy cash position, achieve... Read More...

Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology

NCT's treatment of neurological disorders combined with Numinus' leadership in psychedelic-assisted therapy will offer opportunity to treat a range of chronic neurological conditions and common concurrent mental health challenges VANCOUVER, BC, July 6, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI),Β a mental health care company adv... Read More...

Numinus Announces Grant of Stock Options

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Jan. 14, 2021 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic... Read More...

Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectometer

Acquisition of industry-leading instrument by Thermo Fisher Scientific will significantly advance psychedelic research and accelerate third-party standardized testing capabilities VANCOUVER, BC, Jan. 13, 2021 -Β Numinus Wellness Inc.Β ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing an... Read More...

Numinus Announces Closing of $17 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Proceeds add to recently executed warrants and options of $8.9 million /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Dec. 29, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing... Read More...

Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming Français

The combination further enhances Numinus' leadership position in evidence-based psychedelic-assisted psychotherapy and health solutions VANCOUVER, BC, Dec. 15, 2020 -Β Numinus Wellness Inc.Β ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, acces... Read More...

Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming

The combination further enhances Numinus' leadership position in evidence-based psychedelic-assisted psychotherapy and health solutions VANCOUVER, BC, Dec. 15, 2020 -Β Numinus Wellness Inc.Β ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, acces... Read More...

Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme

Β First-of-its-kind policy amendment will allow legal access to evidence-based treatments to those in need before formal drug approvalΒ  VANCOUVER, BC, Dec. 11, 2020 - Numinus Wellness Inc.Β ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, access... Read More...

Numinus Wellness Inc. Announces an Increase to the Previously Announced Bought Deal Public Offering

/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./VANCOUVER, BC, Dec. 7, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and suppo... Read More...

Ontario Lottery and Gaming Corporation – MidDay lottery winning numbers – Nov. 18, 2020

Numinus Bioscience's developments include harvesting its first flush of Psilocybe mushrooms at its Health Canada licensed facility.VANCOUVER, BC, Oct. 22, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use ... Read More...

Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory

Numinus progresses on its ecosystem approach to the ultimate delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies VANCOUVER, BC, Sept. 24, 2020 -Β Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, ac... Read More...

Numinus Announces Listing of Warrants

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Sept. 18, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centred around developing and supporting the safe, evidence-based, accessible use of psychedelic... Read More...

Numinus Announces Filing of Final Short Form Prospectus for Offering of up to $4,000,000

/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/VANCOUVER, BC, Sept. 3, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted ther... Read More...

Numinus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms

Numinus becomes first publicly traded company in Canada approved to conduct research of this kind under a Health Canada licence VANCOUVER, BC, June 11, 2020 - Numinus Wellness Inc. (TSX-V:NUMI) ("Numinus") has received Health Canada approval to amend the Company's existing Licence under the Controlled Drug and Substances Act to allow Numi... Read More...